GRASIM INDUSTRIES LIMITED.cdr - SMC Global Securities Ltd

2 downloads 175 Views 538KB Size Report
Aug 21, 2018 - The caustic soda prices in India moderated during the quarter led by .... is regulated by the Securities
Quarterly Result Update

GRASIM INDUSTRIES LIMITED August 21, 2018 Consolidated Results

Current Price:

`1042.05

In Cr. Qtr Ended

Qtr Ended

Jun. 18

Jun. 17

VAR %

16856.70

10986.09

53

22.95

19.87

3868.74

2182.80

77

232.95

236.08

-1

PBIDT

4101.69

2418.88

70

Net Finance Charges

1296.41

149.47

767

PBDT

2805.28

2269.41

24

767.05

443.16

73

2038.23

1826.25

12

0.00

-31.48

-100

PBT after EO

2038.23

1794.77

14

Tax expense

680.34

545.64

25

1357.89

1249.13

9

41.62

-1.03

-4141

1399.51

1248.10

12

21.28

26.73

Revenue from Operations OPM (%) OP Other income

STOCK DATA BSE Code NSE Symbol Reuters Bloomberg

500300 GRASIM

Depreciation

GRAS.BO

PBT before EO

GRASIM IN

EO

VALUE PARAMETERS 52 W H/L(Rs) Mkt. Cap.(Rs Cr) Latest Equity(Subscribed) Latest Reserve (cons.)

PAT 1299.90/915.00 68522.94 131.52 57230.37

Latest EPS (cons.) -Unit Curr.

62.26

Latest P/E Ratio -cons

16.74

Latest Bookvalue (cons.) -Unit Curr.

872.32

Share of Profit of Associates Profit after Minority Interest and Share of profit of Associates EPS (Rs)

Grasim Industries Ltd. reported its highest quarterly profit in nearly nine years, surpassing estimates.

Latest P/BV - cons

1.19

Consolidated net sales revenue of the company advanced 53% to Rs 16856.70 crore during

Dividend Yield -%

0.59

quarter ended June 2017. Operating margin (OPM) went up by 308 bps to 22.95%. and the

Face Value

2

operating profit advanced by 77% at Rs 3868.74 crore. The other income down by 1% to Rs 232.95 crore, thus the PBIDT rose by 70% to Rs 4101.69 crore. The Company interest cost jumped to Rs 1296.41 crore and depreciation rose 76% to Rs 767.05 crore. Thus, the PBT before EO grew by 12% to Rs 2038.23 crore. The Tax Expense

SHARE HOLDING PATTERN (%) Description as on

increased 25% to Rs 680.34 crore. After deducting tax expenses, the PAT before MI and Share

% of Holding 30/06/2018

of profits from Associate rose by 50% to Rs 1092.92 crore. After accounting Minority interest of Rs 1357.89 crore, up 9%, and Share of profits from associates of Rs 41.62 crore, the

Foreign

30.78

Consolidated Net Profit, as a result, surged 12% to Rs 1399.51 crore.

Institutions

15.11

Viscose Business

Govt Holding Non Promoter Corp. Hold.

0 3.61

Promoters

40.09

Public & Others

10.42

The Net Revenue for Q1FY19 at Rs.2,480 Cr. was higher by 35% and EBITDA at Rs.586 Cr. by 68%. The VSF business reported its highest ever quarterly production and sales volume of 134KT and 132KT respectively. The share of the domestic sales in the overall sales rose to 82% in Q1FY19 vis-à-vis 69% in Q1FY18. This was primarily driven by expansion of the domestic market, aided by brand LIVA initiative of the Company. The debottlenecking of the VSF capacity at multiple plant locations is almost complete and is reflected in the production volumes of the current quarter (Q1FY19).

1

Grasim is committed to achieve global benchmarks in sustainability through close loop production / European Union Best Available Technologies (EUBAT) technology. The Company’s overseas pulp JVs registered an improvement in operational and financial performance on the back of strong pulp realization and a continued focus on cost optimisation. The recently announced brownfield capacity expansion plan of 219 KTPA at Vilayat is under implementation. Project related work has commenced with the placement of orders for long lead time equipments.

Chemical Business The caustic soda prices in India moderated during the quarter led by temporary softening in global caustic soda prices. The underlying demand from the user industry (Alumina and Textile) continues to remain buoyant. The 146 KTPA Brownfield expansion of caustic soda at Vilayat was commissioned during the quarter. Net Revenue for the quarter rose by 46% YoY to Rs.1,579 Cr. and EBITDA by 103% YoY to Rs.495 Cr. Better realization and higher sales volume were the main drivers. The management focus on increasing the volume of speciality products (chlorine based value added products) continues. The Board has approved the expansion plans for caustic soda and Speciality chemicals at the existing locations entailing a total capex of Rs.1,112 Cr. This would increase caustic soda capacity by 14% to 1,310 KTPA by FY22.

Capex Plan The capex plan of ~ Rs.7,500 Cr. (at standalone level) is under execution for raising capacities in both VSF and Chemical businesses, apart from capex earmarked for maintenance at various plants. A significant portion of our capital expenditure will be funded by internal accruals during FY19-FY21.

Cement Subsidiary - UltraTech UltraTech reported Consolidated Sales Revenue of Rs.9,021 Cr. up 28% (YoY) and EBITDA of Rs.1,763 Cr. in Q1FY19. The consolidated sales volume registered an increase of 29% on YoY basis to 18.01mtpa. The acquisition of the Cement business of Century Textiles and Industries Ltd., in terms of a Scheme of Arrangement is in the process of requisite approvals. On completion of the said acquisition and ongoing capacity expansions, UltraTech’s total capacity will stand augmented to 111.1 Mn MTPA inclusive of its overseas capacity.

Financial Services Subsidiary – Aditya Birla Capital Limited (ABCL) Revenue and Net Profit for Q1FY19 stood at Rs. 2,978 Cr. and Rs.216 Cr., an increase of 32% and 26% YoY respectively. All the key businesses have been the contributors. NBFC lending book grew 23% YoY to Rs.44,408 Cr. The Housing Finance book grew by 1.9x YoY to Rs.9,176 Cr. in Q1FY19. Its Asset Management business ranked No.3 in India with the Average Assets under management up by 19% YoY to Rs.2,67,176 Cr. The business has registered an overall domestic market share of 10.7% with Equity AUM (incl. Alternate and Offshore) at ~ Rs.1,00,000 Cr. in

2

Q1FY19. The Life Insurance business reported a 40% growth in the Individual First Year Premium to Rs.227 Cr. It has improved its individual rank by 2 spots to No.71 amongst insurance companies. The Health Insurance business has reported a gross written premium of Rs.76 Crore in Q1FY19. 1Rank and Market share amongst players (Excl. LIC) based on individual FYP: source IRDAI

Outlook The VSF business will continue to focus on expanding the market in India by partnering with the textile value chain, achieving better customer connect through brand LIVA and enriching the product mix through a larger share of specialty fibre. However, new capacities likely to come on stream in China may impact the global VSF prices in the near term. The Chemical business is witnessing a healthy growth with the completion of its recent capacity expansion. Further growth is expected from the new capex plan for caustic soda expansion and new product lines for specialty chemicals. In Cement, with the cement industry now in its up-cycle, the demand is expected to be healthy. The key drivers being higher government budget allocation for infrastructure and rural development, increased rural housing demand consequent to increase in Minimum Support Price for kharif crop and pre-election spending. With the additional capacities acquired by the Company through the organic and inorganic route and its rapid rampup, UltraTech is very well placed to participate in the growth of the economy. In Financial Services, ABCL is in the unique position of being able to provide Universal Financial Solutions to meet customers’ money needs for life. ABCL’s focused customercentric approach under a single brand “Aditya Birla Capital” enables it to chart a differentiated and disciplined path to growth.

3

E-mail: [email protected] Corporate Office: 11/6B, Shanti Chamber, Pusa Road, New Delhi - 110005 Tel: +91-11-30111000 www.smcindiaonline.com

Mumbai Office: Lotus Corporate Park, A Wing 401 / 402 , 4th Floor , Graham Firth Steel Compound, Off Western Express Highway, Jay Coach Signal, Goreagon (East) Mumbai - 400063 Tel: 91-22-67341600, Fax: 91-22-67341697

Kolkata Office: 18, Rabindra Sarani, Poddar Court, Gate No-4, 5th Floor, Kolkata - 700001 Tel.: 033 6612 7000/033 4058 7000 Fax: 033 6612 7004/033 4058 7004

SMC Global Securities Ltd. (hereinafter referred to as “SMC”) is regulated by the Securities and Exchange Board of India (“SEBI”) and is licensed to carry on the business of broking, depository services and related activities. SMC is a registered member of National Stock Exchange of India Limited, Bombay Stock Exchange Limited, MSEI (Metropolitan Stock Exchange of India Ltd) and M/s SMC Comtrade Ltd is a registered member of National Commodity and Derivative Exchange Limited and Multi Commodity Exchanges of India and other commodity exchanges in India. SMC is also registered as a Depository Participant with CDSL and NSDL. SMC’s other associates are registered as Merchant Bankers, Portfolio Managers, NBFC with SEBI and Reserve Bank of India. It also has registration with AMFI as a Mutual Fund Distributor. SMC is a SEBI registered Research Analyst having registration number INH100001849. SMC or its associates has not been debarred/ suspended by SEBI or any other regulatory authority for accessing /dealing in securities market. SMC or its associates or its Research Analyst or his relatives do not hold any financial interest in the subject company interest at the time of publication of this Report. SMC or its associates or its Research Analyst or his relatives do not hold any actual/beneficial ownership of more than 1% (one percent) in the subject company, at the end of the month immediately preceding the date of publication of this Report. SMC or its associates its Research Analyst or his relatives does not have any material conflict of interest at the time of publication of this Report. SMC or its associates/analyst has not received any compensation from the subject company covered by the Research Analyst during the past twelve months. The subject company has not been a client of SMC during the past twelve months. SMC or its associates has not received any compensation or other benefits from the subject company covered by analyst or third party in connection with the present Research Report. The Research Analyst has not served as an officer, director or employee of the subject company covered by him/her and SMC has not been engaged in the market making activity for the subject company covered by the Research Analyst in this report. The views expressed by the Research Analyst in this Report are based solely on information available publicly available/internal data/ other reliable sources believed to be true. SMC does not represent/ provide any warranty expressly or impliedly to the accuracy, contents or views expressed herein and investors are advised to independently evaluate the market conditions/risks involved before making any investment decision. The research analysts who have prepared this Report hereby certify that the views /opinions expressed in this Report are their personal independent views/opinions in respect of the subject company.

Disclaimer: This Research Report is for the personal information of the authorized recipient and doesn't construe to be any investment, legal or taxation advice to the investor. It is only for private circulation and use. The Research Report is based upon information that we consider reliable, but we do not represent that it is accurate or complete, and it should not be relied upon as such. No action is solicited on the basis of the contents of this Research Report. The Research Report should not be reproduced or redistributed to any other person(s)in any form without prior written permission of the SMC. The contents of this material are general and are neither comprehensive nor inclusive. Neither SMC nor any of its affiliates, associates, representatives, directors or employees shall be responsible for any loss or damage that may arise to any person due to any action taken on the basis of this Research Report. It does not constitute personal recommendations or take into account the particular investment objectives, financial situations or needs of an individual client or a corporate/s or any entity/s. All investments involve risk and past performance doesn't guarantee future results. The value of, and income from investments may vary because of the changes in the macro and micro factors given at a certain period of time. The person should use his/her own judgment while taking investment decisions. Please note that SMC its affiliates, Research Analyst, officers, directors, and employees, including persons involved in the preparation or issuance if this Research Report: (a) from time to time, may have long or short positions in, and buy or sell the securities thereof, of the subject company(ies) mentioned here in; or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company(ies) discussed herein or may perform or seek to perform investment banking services for such company(ies) or act as advisor or lender/borrower to such subject company(ies); or (c) may have any other potential conflict of interest with respect to any recommendation and related information and opinions. All disputes shall be subject to the exclusive jurisdiction of Delhi High court.

4